Wednesday, July 8, 2026

Drug profile · INN

chenodiol

chenodiol (CHENIX) is a bile acid receptor fxr agonist. Associated with Mirum Pharmaceuticals International B.V.. Route of administration: oral. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — chenodiol
US status
approved
Class
Route
ORAL
Patents
0
Programs
0
Data quality
0.89

Quick answer

chenodiol (CHENIX) is a bile acid receptor fxr agonist. Associated with Mirum Pharmaceuticals International B.V.. Route of administration: oral. Current US regulatory status: approved.

Key facts

INN chenodiol
Brand CHENIX
Mechanism Bile acid receptor FXR agonist
Target Bile acid receptor
Route ORAL
Formulation TABLET

Mechanism of action

Bile acid receptor FXR agonist

Primary target: Bile acid receptor

Approval history

Authority Status Date
FDA approved

Related & competitor drugs

  1. ursodiol Bile acid receptor FXR agonist
  2. obeticholic acid Alimentary tract and metabolism (A05)
  3. chenodeoxycholic acid Alimentary tract and metabolism (A05)
  4. ursodeoxycholic acid Bile acid receptor FXR agonist

Frequently asked questions

What is chenodiol?

chenodiol (CHENIX) is a bile acid receptor fxr agonist. Associated with Mirum Pharmaceuticals International B.V.. Route of administration: oral. Current US regulatory status: approved.

What is the brand name for chenodiol?

CHENIX is a marketed brand name for chenodiol. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of chenodiol?

chenodiol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.